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Introduction
Diabetes mellitus (DM) is the commonest metabolic disease 
currently affecting more that 250 million people worldwide and 
it costs the Governments of the world more than £800billion 
to diagnose, treat and care for diabetic patients. DM is 
associated with numerous long-term complications including 
cardiomyopathy, nephropathy, neuropathy and retinopathy. This 
review addresses diabetic painful neuropathy (DPN) which is 
one of the well-known complications of diabetes and it affects 
up to 53% of diabetic population [1]. It is the most common form 
of painful neuropathy [2]. It manifests with varying description 
from mild pins and needle sensation to the stabbing pain, 
burning, unremitting or even described as electric shock. The 
most common feature is cutaneous hypersensitivity leading 
to acute distress on contact with an external stimulus, such 
as clothing [3]. The pathogenesis of DPN is mainly caused by 
inflammatory process [4] and strongly correlates with longer 
duration of the diabetes and poor glycaemic control [5-18].
Treatment induces acute neuropathy due to rapid glycaemic 
control has been reported in literature as ‘insulin neuritis’ that 
usually manifests with severe excruciating neuropathic pain in 
the first month of initiation of insulin or oral hypoglycaemic 
agents. Symptoms usually last up to 6 months and respond to 
treatment that is usually needed up to 6 months [3]. Insulin 
neuritis was first described by Caravati [19] in 1933. He 
reported a diabetic woman with numbness, tingling, and 
shooting pains in the lower extremities that appeared four 
weeks after the initiation of insulin. The pain increased despite 
the use of analgesics and sedatives, but resolved within 3 days 
of stopping insulin concurrent with severe hyperglycaemia. 
Further attempts at the use of insulin resulted in similar levels 
of pain. He called the condition “insulin neuritis” [19]. The word 
insulin neuritis is a misnomer, as it can also be induced by oral 
hypoglycaemic agent [20]. The cause is not directly by insulin 
but mainly due to the change in flux of blood glucose caused by 
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rapid change in blood glucose level following pharmacological 
treatment [21].
Symptoms
There are several studies and case reports in the literature 
about insulin neuritis with varying presentation after starting 
insulin or oral hypoglycaemic agents. These reports described 
the most common features as generalized pain bilaterally mainly 
distally in feet with burning sensation, hypersensitivity and 
contact discomfort of the skin within 2 to 4 weeks [20,22,23]. 
It may present with truncal neuropathy [24-27], autonomic 
neuropathy [28], worsening of retinopathy [29], and even with 
profound weight loss [22,30-32].
Generalize pain mainly distally
The most common presentation of Insulin neuritis is 
symmetrical and bilateral distal neuropathic pain mainly 
involving feets [3]. In one observational study on 6 patients 
with diabetes, all experienced severe excruciating bilateral 
neuropathic pain mainly in feet after 2-4 weeks of insulin 
treatment with rapid reduction of blood glucose up to one fifth 
of initial levels. This improved in all cases with symptomatic 
treatment allowing discontinuation of therapy in 3-8 months 
[20]. A case report on a newly diagnosed type 1 diabetes 
patient described development of severe pain in his feet, which 
prevented him from walking, after initiation of insulin. The 
HbA1c of that patient dropped from 14.1 to 7.6%, and 3 months 
after presentation, the patient showed dramatic improvement 
and regained his ability to walk [33]. There is another similar 
case report of painful neuropathy on 15th day of treatment with 
intense insulin therapy following poor glycaemic control period 
of 8 years. He responded well on symptomatic treatment on day 
3 on venlafaxine [34].
Diabetic neuropathic cachexia 
Painful neuropathy is sometimes associated with profound 
weight loss and called “Diabetic neuropathic cachexia”. This has 
also been reported with insulin neuritis that could last up to a year. 
The exact mechanism and cause is unknown [3]. It is observed 
that constant pain and discomfort can cause loss of appetite 
and low mood which results in patients not eating enough and 
start losing weight. Most patients respond well with neuropathic 
pain treatment which gives pain relief and regain weight. In one 
observational study, 9 diabetic patients experienced painful 
neuropathy with constant burning pain mainly in the legs, 
especially distally. There was marked troublesome allodynia 
associated with profound weight loss along with depression with 
impotence. These severe manifestations subsided in most cases 
in 6 months and in all cases in 10 months [22]. There is another 
case report in which patient presented with painful neuropathy, 
profound weight loss after initiation of insulin therapy within 3 
months [31].
Truncal neuropathy
Insulin neuritis may precipitate focal neuropathic pain called 
“Truncal neuropathy” on specific dermatome region. Truncal 
neuropathy in diabetes presents with neuropathic pain such as 
a hypoesthesia, regional hyperalgesia, allodynia and sometime 
focal weakness in specific dermatome region. It usually presents 
with unilateral abdominal or thoracic wall pain [3,25]. There 
was one case of insulin neuritis which presented with painful 
neuropathy with paraesthesia and hyperesthesia restricted to 
the abdomen and this was associated with profound weight loss. 
The haemoglobin A (1c) had dropped from 12% to 7.5% within 
5 months, following rapid improvement in glycaemic control. 
On investigation, there was no indication of disease in intra-
abdominal area. The symptoms improved dramatically within 4 
months after symptomatic treatment [30].
It is not uncommon that these patients have to undergo a 
number of investigations to determine the cause of pain before 
having the diagnosis of truncal neuropathy [24-27,30]. There 
are several cases of truncal neuropathy that were misdiagnosed 
initially as for example hernia due to focal weakness on 
abdominal wall [26], angina due to left sided chest wall pain [25] 
and painless gall stones due to focal sensory deficit complicated 
with painless jaundice secondary gall stone [27]. The diagnosis 
of truncal neuropathy is essentially clinical and positive 
recognition of neuropathic element of pain is the key factor. Most 
people respond well on neuropathic treatment and usually settle 
in 3 to 12 months. 
Autonomic neuropathy
Autonomic dysfunction is one of the complications of 
diabetes3. It manifests with one or more of the following: 
erectile dysfunction, gatsroparesis, neurogenic bladder, dry 
feet, depressed cough reflex, postural hypotension or high 
blood flow to foot [35,36]. Insulin neuritis has been reported 
to precipitate autonomic neuropathy. In one prospective 
study on 16 diabetic patients followed up for 18 months, all 
the patients develop severe painful neuropathy in 8 weeks of 
intense glycaemic treatment. All individuals with treatment for 
induced neuropathy had evidence of autonomic dysfunction 
on testing and exhibited symptoms of autonomic impairment. 
Approximately, 69% of cohort had systolic blood pressure falls 
> 20 mmHg. Symptoms of autonomic dysfunction were more 
prevalent and more severe in subjects with type 1 diabetes, 
particularly with respect to symptoms of orthostatic intolerance 
and gastrointestinal function. Urinary frequency, nocturia and 
anhidrosis were reported more frequently in individuals with 
type 2 diabetes [28].
Retinopathy
Retinopathy is a well-known complication of diabetes and 
directly related with poor glycaemia and duration of diabetes 
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[37]. It is also proven that better glycaemic control prevent 
worsening of retinopathy [38]. Insulin neuritis with rapid flux 
of blood glucose causes structural changes at endoneural blood 
vessels of nerves which resemble with retinopathic changes in 
retina [39]. Rapid drop in blood glucose in poorly controlled 
diabetes may exert the same changes in retina, thus worsening 
the retinopathy. In one large observational study, 87 patients 
were divided in 3 groups of varying glycaemic control. These 
included a group of poor glycaemic control corrected rapidly, 
poor glycaemic control not corrected and good control group. 
The progression rate of diabetic maculopathy was significantly 
higher in the group that underwent rapid control than in the 
other 2 groups (P <02). Patients with moderate to severe non-
proliferative diabetic retinopathy preoperatively in the rapid 
control group had significantly higher progression rates of 
diabetic retinopathy and maculopathy (P <002 and p<008, 
respectively) [40].
Pathogenesis
In 1992 Boulton first described the observation that acute 
painful neuropathy might follow sudden change in glycaemia 
control suggesting that blood glucose flux could precipitate 
pain. Sudden changes in glycaemia may contribute to the 
generation of impulses or even induce relative hypoxia in nerve 
fibres, indicating that it is the combination of structural and 
functional changes in peripheral nerves which cause the pain 
[21]. This observation was experimentally tested by Kihara 
et al. [41] in 1994 on rats. In their study, they infused insulin 
under non- hypoglycaemic conditions and evaluated its effect 
on endoneurial oxygen tension, nerve blood flow, and the 
oxy-haemoglobin dissociation curve of peripheral nerves in 
normal and diabetic rats. Their results showed that insulin 
administration could cause a reduction in nerve nutritive 
blood flow and an increase in arterio-venous shunt flow. When 
the latter was eliminated by the closure of arterio-venous 
shunts (infusion of 5-hydroxytryptamine), endoneurial oxygen 
reverted to normal. These findings clearly indicate a deleterious 
vasoactive effect of insulin and may explain the development of 
insulin neuritis [41]. 
In 1996 Tesfaye et al observed neurovascular changes 
in vivo in five human diabetic patients with insulin neuritis. 
These patients presented with severe sensory symptoms but 
clinical examination and electrophysiological tests were normal 
except with one subject who had severe autonomic neuropathy 
and all tests were abnormal. On sural nerve exposure in vivo, 
epineural blood vessels showed severe structural abnormalities 
resembling the retinopathy changes normally seen in the 
retina, including arteriolar attenuation, tortuosity and aterio-
venous shunting and proliferating new vessels formation. 
They hypothesized that the structural abnormalities with new 
vessels formation in epineural blood vessels cause steal effect 
and hence results in hypoxia and neuropathic pain [39]. It can 
now be postulated that sudden change in glycaemic control can 
cause flux effect resulting in structural and functional changes at 
the epineural blood vessels of nerves which in turn can lead to 
neuropathic pain “Insulin neuritis (Figure 1)” [21,39].
Figure 1: A flow diagram showing the pathogenesis of insulin 
neuritis
Treatment
Management of neuropathic pain in “insulin neuritis” 
is symptomatic including first line medication tricyclic 
antidepressants (Amitriptyline) or selective serotonin uptake 
inhibitor (Duloxetine). Second line medications include anti-
epileptic medications (Gabapentin, Pregabalin, Carbamazepine 
and Topiramate) and Opioids. Most patients recover within 6 
months of onset of insulin neuritis [3].
Conclusion
Figure 2: Arteriolar attenuation, tortuosity and aterio-
venous shunting and proliferating new vessels formation of 
vasanervosum seen in sural nerve of patient with insulin neuritis 
(photo courtesy of Tesfaye and Boulton [9]).
The flow diagram in Figure 2 summarises the pathogenesis 
of insulin neuritis. With increasing prevalence of diabetes and 
its complications, both health professional and patients are keen 
to have good glycaemic control in order to prevent long term 
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complications [42]. Most of the time it is not a problem but on 
several occasions intense treatment for rapid glycaemic control 
may cause insulin neuritis. This is presumed to be caused 
by change in glucose flux which can result in structural and 
functional changes at the nerves leading to hypoxia. This in turn 
can precipitate neuropathic pain and the whole phenomenon is 
called “insulin neuritis”. It usually manifests distally in feet and is 
bilateral with burning sensation, hypersensitivity and allodynia. 
It could affect focally - truncal neuritis and may present with 
neuropathic pain and/or weakness in dermatomal region. 
Similarly, it may present with autonomic symptoms. Constant 
pain may cause cachexia and loss of appetite which can result 
in significant weight loss. Most patients respond well with 
neuropathic treatment and recover within 6 months. It is very 
important to be aware that treatment induced insulin neuritis 
can have significant impact on the quality of the life of the diabetic 
patient. This can be easily prevented by gradual glycaemic 
control and by symptomatic treatment as necessary. Healthcare 
professionals need to be aware of this condition when managing 
poorly controlled diabetic patients and should consider gradual 
titration of the pharmacological agents employed to treat the 
patients.
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